The Family Firm’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,691
Closed -$684K 131
2025
Q1
$684K Sell
9,691
-363
-4% -$25.6K 0.15% 95
2024
Q4
$661K Buy
10,054
+31
+0.3% +$2.04K 0.15% 94
2024
Q3
$708K Buy
10,023
+51
+0.5% +$3.6K 0.15% 98
2024
Q2
$661K Buy
9,972
+44
+0.4% +$2.92K 0.15% 94
2024
Q1
$674K Sell
9,928
-410
-4% -$27.8K 0.16% 92
2023
Q4
$639K Buy
10,338
+333
+3% +$20.6K 0.16% 91
2023
Q3
$590K Sell
10,005
-414
-4% -$24.4K 0.17% 91
2023
Q2
$622K Sell
10,419
-468
-4% -$27.9K 0.16% 93
2023
Q1
$636K Buy
10,887
+492
+5% +$28.7K 0.18% 89
2022
Q4
$645K Sell
10,395
-1,179
-10% -$73.2K 0.19% 92
2022
Q3
$654K Sell
11,574
-165
-1% -$9.32K 0.21% 84
2022
Q2
$750K Sell
11,739
-285
-2% -$18.2K 0.22% 79
2022
Q1
$779K Sell
12,024
-2,283
-16% -$148K 0.2% 81
2021
Q4
$952K Buy
14,307
+57
+0.4% +$3.79K 0.25% 73
2021
Q3
$885K Buy
14,250
+2,133
+18% +$132K 0.23% 75
2021
Q2
$750K Buy
12,117
+585
+5% +$36.2K 0.2% 80
2021
Q1
$683K Buy
11,532
+3
+0% +$178 0.2% 76
2020
Q4
$706K Sell
11,529
-333
-3% -$20.4K 0.21% 75
2020
Q3
$647K Buy
11,862
+54
+0.5% +$2.95K 0.23% 72
2020
Q2
$606K Buy
11,808
+1,194
+11% +$61.3K 0.23% 71
2020
Q1
$476K Hold
10,614
0.2% 74
2019
Q4
$567K Sell
10,614
-135
-1% -$7.21K 0.19% 75
2019
Q3
$501K Buy
10,749
+2,535
+31% +$118K 0.18% 83
2019
Q2
$413K Buy
8,214
+1,095
+15% +$55.1K 0.15% 91
2019
Q1
$365K Buy
7,119
+1,278
+22% +$65.5K 0.13% 97
2018
Q4
$274K Buy
5,841
+27
+0.5% +$1.27K 0.11% 109
2018
Q3
$325K Buy
5,814
+216
+4% +$12.1K 0.12% 106
2018
Q2
$282K Sell
5,598
-1,647
-23% -$83K 0.11% 105
2018
Q1
$356K Buy
7,245
+1,974
+37% +$97K 0.14% 95
2017
Q4
$271K Buy
+5,271
New +$271K 0.11% 109